Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients-Reference-Cited by-同舟云学术

Transplant-associated thrombotic microangiopathy: elucidating prevention strategies and identifying high-risk patients

Published:2021-08-03 Issue:8 Volume:14 Page:751-763
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Jodele Sonata¹²,Sabulski Anthony¹²

Affiliation:

1. Division of Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Disease Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA

2. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2021.1960816

Reference90 articles.

1. A new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury

2. Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder

3. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults

4. Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation

5. Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. THE UTILITY OF THE NORMAL THIN SECTION SKIN BIOPSY IN THE ASSESSMENT OF SYSTEMIC/EXTRACUTANEOUS DISEASE;Clinics in Dermatology;2024-09

2. Eculizumab treatment in paediatric patients diagnosed with aHUS after haematopoietic stem cell transplantation: a HSCT-TMA case series from Japanese aHUS post-marketing surveillance;Bone Marrow Transplantation;2023-12-15

3. Survival analysis of transplant-associated thrombotic microangiopathy under different diagnostic criteria and the efficacy of plasma exchange;Annals of Transplantation;2023-06-02

4. Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children;Blood Advances;2023-04-27

5. Reeling in complement in transplant‐associated thrombotic microangiopathy: You're going to need a bigger boat;American Journal of Hematology;2023-03-31